• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一大群意大利1型糖尿病门诊患者的血糖控制与微血管并发症

Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.

作者信息

Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R

机构信息

Diabetes Unit, A.O. Ospedali Riuniti, Bergamo, Italy.

出版信息

Diabetes Nutr Metab. 2002 Aug;15(4):232-9.

PMID:12416660
Abstract

The purpose of this cross-sectional study was to evaluate the degree of metabolic control, the prevalence of microvascular complications (nephropathy, retinopathy, and peripheral neuropathy) and their association with risk factors for cardiovascular diseases in all adult Type 1 diabetic out-patients attending 2 Diabetes Clinics of Northern Italy over 12 months. A total of 458 patients (mean age 37 +/- 12 yr, duration of diabetes 15.3 +/- 10.6 yr, BMI 23.2 +/- 3.1 kg/m2) were studied. Clinical characteristics and microvascular complications were evaluated. The proportion of patients with a good glycaemic control (HbA1c < 7%) was 14.7%. Nephropathy was observed in 24.4%, retinopathy in 41%, peripheral neuropathy in 23.7%. The prevalence of hypertension was 30.3%. Microvascular complications were associated with age, duration of diabetes, systolic blood pressure, creatinine, triglycerides and cholesterol plasma levels. Mean HbA1c was 8.5 +/- 1.6. Patients with HbA1c levels < 7% presented a lower prevalence of complications and lower levels of cholesterol, triglycerides, systolic blood pressure than patients with HbA1c > 9%. Our study indicates that an acceptable metabolic control is achieved in a too low proportion of Type 1 diabetic patients, even under multiple insulin injections. The association of poor metabolic control and microalbuminuria identifies a group of patients at higher risk of diabetic complications.

摘要

这项横断面研究的目的是评估在12个月期间,所有就诊于意大利北部2家糖尿病诊所的成年1型糖尿病门诊患者的代谢控制程度、微血管并发症(肾病、视网膜病变和周围神经病变)的患病率及其与心血管疾病危险因素的关联。共研究了458例患者(平均年龄37±12岁,糖尿病病程15.3±10.6年,体重指数23.2±3.1kg/m²)。评估了临床特征和微血管并发症。血糖控制良好(糖化血红蛋白<7%)的患者比例为14.7%。观察到肾病的患病率为24.4%,视网膜病变为41%,周围神经病变为23.7%。高血压患病率为30.3%。微血管并发症与年龄、糖尿病病程、收缩压、肌酐、甘油三酯和胆固醇血浆水平相关。平均糖化血红蛋白为8.5±1.6。糖化血红蛋白水平<7%的患者并发症患病率较低,胆固醇、甘油三酯和收缩压水平也低于糖化血红蛋白>9%的患者。我们的研究表明,即使在多次注射胰岛素的情况下,1型糖尿病患者中达到可接受代谢控制的比例也过低。代谢控制不佳与微量白蛋白尿的关联确定了一组糖尿病并发症风险较高的患者。

相似文献

1
Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.一大群意大利1型糖尿病门诊患者的血糖控制与微血管并发症
Diabetes Nutr Metab. 2002 Aug;15(4):232-9.
2
Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.芬兰胰岛素依赖型糖尿病并发症的发生率及其相互关系。
Acta Diabetol. 1997 Mar;34(1):33-8. doi: 10.1007/s005920050062.
3
Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.最佳血糖和血压目标而非血脂目标与降低糖尿病微血管并发症的患病率相关。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102241. doi: 10.1016/j.dsx.2021.102241. Epub 2021 Aug 8.
4
The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.1型糖尿病患者视网膜病变、肾病、心血管疾病与长期代谢控制之间的关联:对442例接受常规护理的成年患者进行的5年随访研究。
Diabetes Res Clin Pract. 1997 Mar;35(2-3):113-21. doi: 10.1016/s0168-8227(97)01386-7.
5
Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.尼日利亚一家三级医疗机构中2型糖尿病微血管并发症的负担及模式
Afr Health Sci. 2015 Dec;15(4):1136-41. doi: 10.4314/ahs.v15i4.12.
6
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.1型糖尿病患者慢性并发症与血糖严格控制时间及血糖达标时间的相关性:一项回顾性横断面真实世界研究
Diabetologia. 2024 Aug;67(8):1527-1535. doi: 10.1007/s00125-024-06171-y. Epub 2024 May 24.
7
Pattern of long-term complications in Sudanese insulin-treated diabetic patients.苏丹接受胰岛素治疗的糖尿病患者的长期并发症模式。
Diabetes Res Clin Pract. 1995 Oct;30(1):59-67. doi: 10.1016/0168-8227(95)01146-3.
8
Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.2 型糖尿病南印度患者微血管并发症的危险因素——Chennai Urban Rural Epidemiology Study(CURES)Eye Study-5。
Diabetes Technol Ther. 2010 Oct;12(10):755-61. doi: 10.1089/dia.2010.0069.
9
Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes.血浆纤维蛋白原水平与 2 型糖尿病微血管并发症的相关性。
J Pak Med Assoc. 2024 Aug;74(8):1441-1448. doi: 10.47391/JPMA.10403.
10
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.1型糖尿病患者血浆唾液酸浓度与微血管和大血管并发症的关系:欧洲糖尿病并发症研究
Diabetes Care. 2001 Feb;24(2):316-22. doi: 10.2337/diacare.24.2.316.

引用本文的文献

1
Polyethylene glycol capped gold nanoparticles ameliorate renal ischemia-reperfusion injury in diabetic mice through AMPK-Nrf2 signaling pathway.聚乙二醇包覆的金纳米粒子通过 AMPK-Nrf2 信号通路改善糖尿病小鼠的肾缺血再灌注损伤。
Environ Sci Pollut Res Int. 2022 Nov;29(51):77884-77907. doi: 10.1007/s11356-022-21235-5. Epub 2022 Jun 10.
2
Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk.1型糖尿病中的心血管疾病:心血管风险的流行病学与管理
J Clin Med. 2021 Apr 20;10(8):1798. doi: 10.3390/jcm10081798.
3
Cardiovascular risk in type 1 diabetes mellitus.
1型糖尿病中的心血管风险
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S7-S13. doi: 10.4103/2230-8210.119489.
4
Prevalence of diabetic retinopathy and cataract in adult patients with type 1 and type 2 diabetes in Russia.俄罗斯1型和2型糖尿病成年患者中糖尿病视网膜病变和白内障的患病率。
Rev Diabet Stud. 2009;6(2):124-9. doi: 10.1900/RDS.2009.6.124. Epub 2009 Aug 10.
5
Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation.吡格列酮通过Akt依赖的VEGF介导机制增强糖尿病小鼠缺血后肢的侧支血流,与PPARγ刺激无关。
Cardiovasc Diabetol. 2009 Sep 8;8:49. doi: 10.1186/1475-2840-8-49.